4-fluoro-8-nitro-6H-dibenzo[b,d]pyran-6-one | 304655-44-5

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 香豆素及其衍生物
• 英文名称: 4-fluoro-8-nitro-6H-dibenzo[b,d]pyran-6-one
• 英文别名: 4-Fluoro-8-nitrobenzo[c]chromen-6-one
• CAS: 304655-44-5
• 化学式: C₁₃H₆FNO₄
• 分子量: 259.193
• InChiKey: SSDRYHUTIOZFOW-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3
• 重原子数：
  19
• 可旋转键数：
  0
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  72.1
• 氢给体数：
  0
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  4-fluoro-8-nitro-6H-dibenzo[b,d]pyran-6-one 在 碘 、 tin(ll) chloride 作用下， 以 乙酸乙酯 为溶剂， 反应 20.0h， 生成 7-Fluoro-2,2,4-trimethyl-1,2-dihydro-6-oxa-1-aza-chrysen-5-one
  参考文献：
  名称：

  Development of progesterone receptor antagonists from 1,2-dihydrochromeno[3,4-f]quinoline agonist pharmacophore

  摘要：

  A series of 1,2-dihydrochromeno[3,4-f]quinoline derivatives was synthesized and tested in biological assays to evaluate the nonsteroidal progesterone receptor modulator pharmacophore (4) as antiprogestins. A number of potent analogues were identified by modification of the substituents at the D-ring. (C) 2003 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(03)00256-7
• 作为产物：
  描述：

  2,3-二氟苯硼酸 在 sodium hydroxide 、 四(三苯基膦)钯 、 sodium hydride 、 sodium carbonate 作用下， 以 四氢呋喃 、 乙醇 、 N,N-二甲基甲酰胺 、 甲苯 为溶剂， 反应 22.0h， 生成 4-fluoro-8-nitro-6H-dibenzo[b,d]pyran-6-one
  参考文献：
  名称：

  Development of progesterone receptor antagonists from 1,2-dihydrochromeno[3,4-f]quinoline agonist pharmacophore

  摘要：

  A series of 1,2-dihydrochromeno[3,4-f]quinoline derivatives was synthesized and tested in biological assays to evaluate the nonsteroidal progesterone receptor modulator pharmacophore (4) as antiprogestins. A number of potent analogues were identified by modification of the substituents at the D-ring. (C) 2003 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(03)00256-7

文献信息

• Tetracyclic progesterone receptor modulator compounds and methods
  申请人：American Home Products Corporation

  公开号：US06358947B1

  公开（公告）日：2002-03-19

  Nonsteroidal compounds that are high affinity, high selectivity modulators for progesterone receptors are disclosed. Also disclosed are pharmaceutical compositions incorporating such compounds, methods for employing the disclosed compounds and compositions for treating patients requiring progesterone receptor agonist, partial agonist or antagonist therapy, intermediates useful in the preparation of the compounds and processes for the preparation of the progesterone receptor modulator compounds.

  公开了具有高亲和力和高选择性的非甾体化合物，这些化合物是孕酮受体的调节剂。还公开了包含此类化合物的药物组合物，以及使用这些化合物和组合物治疗需要孕酮受体激动剂、部分激动剂或拮抗剂疗法的患者的方祛。此外，还提供了在制备这些化合物中使用的中间体以及制备孕酮受体调节剂化合物的工艺。
• US6358947B1
  申请人：——

  公开号：US6358947B1

  公开（公告）日：2002-03-19
• Development of progesterone receptor antagonists from 1,2-dihydrochromeno[3,4-f]quinoline agonist pharmacophore
  作者：Lin Zhi、Josef D Ringgenberg、James P Edwards、Christopher M Tegley、Sarah J West、Barbara Pio、Mehrnouch Motamedi、Todd K Jones、Keith B Marschke、Dale E Mais、William T Schrader

  DOI：10.1016/s0960-894x(03)00256-7

  日期：2003.6

  A series of 1,2-dihydrochromeno[3,4-f]quinoline derivatives was synthesized and tested in biological assays to evaluate the nonsteroidal progesterone receptor modulator pharmacophore (4) as antiprogestins. A number of potent analogues were identified by modification of the substituents at the D-ring. (C) 2003 Elsevier Science Ltd. All rights reserved.